As a healthcare professional you want the best outcomes for your patient. Much of that outcome relies on the treatment plan that comes from an accurate diagnosis. MolecuLight i:X can aid in that process with proven results.
Wound-related outcomes and antimicrobial dressing costs were quantified over 1-year before (2018/2019) and after (2019/2020) incorporating fluorescence imaging into routine practice. The period of fluorescence imaging saw a 27% increase in the number of wounds seen, yet annual antimicrobial dressing expenditure decreased by 33%.
23% increase in 12 week wound healing rate
33% decrease in antibiotic prescribing
47% decrease in antimicrobial spending per wound
MolecuLight is empowering wound care clinicians with breakthrough technology. It doesn’t stop there. The secret to embracing the full potential of the MolecuLight i:X is through our world-class training and support.
Wound care clinicians would have access to:
Learn how to use the MolecuLight i:X Imaging Device with this series of training videos.
Indepth training courses and certification tests for the MolecuLight i:X Imaging Device, including how to accurately and effectively interpret MolecuLight i:X fluorescence images.
Diagnostic Accuracy of Point-of-Care Fluorescence Imaging for the Detection of Bacterial Burden in Wounds:
Results from the 350-Patient Fluorescence Imaging Assessment and Guidance Trial, (2020).
Routine Fluorescence Imaging to Detect Wound Bacteria Reduces Antibiotic Use and Antimicrobial Dressing Expenditure. While Improving Healing Rates: Retrospective Analysis of 229 Foot Ulcers, (2020)